Literature DB >> 33922633

Centrosome Dynamics and Its Role in Inflammatory Response and Metastatic Process.

Massimo Pancione1, Luigi Cerulo1, Andrea Remo2, Guido Giordano3, Álvaro Gutierrez-Uzquiza4,5, Paloma Bragado4,5, Almudena Porras4,5.   

Abstract

Metastasis is a process by which cancer cells escape from the location of the primary tumor invading normal tissues at distant organs. Chromosomal instability (CIN) is a hallmark of human cancer, associated with metastasis and therapeutic resistance. The centrosome plays a major role in organizing the microtubule cytoskeleton in animal cells regulating cellular architecture and cell division. Loss of centrosome integrity activates the p38-p53-p21 pathway, which results in cell-cycle arrest or senescence and acts as a cell-cycle checkpoint pathway. Structural and numerical centrosome abnormalities can lead to aneuploidy and CIN. New findings derived from studies on cancer and rare genetic disorders suggest that centrosome dysfunction alters the cellular microenvironment through Rho GTPases, p38, and JNK (c-Jun N-terminal Kinase)-dependent signaling in a way that is favorable for pro-invasive secretory phenotypes and aneuploidy tolerance. We here review recent data on how centrosomes act as complex molecular platforms for Rho GTPases and p38 MAPK (Mitogen activated kinase) signaling at the crossroads of CIN, cytoskeleton remodeling, and immune evasion via both cell-autonomous and non-autonomous mechanisms.

Entities:  

Keywords:  Rho GTPases; centrosome; chromosome instability; p38 MAPK; tumor microenvironment

Year:  2021        PMID: 33922633     DOI: 10.3390/biom11050629

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  119 in total

1.  Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.

Authors:  Sandra L Clement; Claudia Scheckel; Georg Stoecklin; Jens Lykke-Andersen
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

Review 2.  The Centrosome Linker and Its Role in Cancer and Genetic Disorders.

Authors:  Andrea Remo; Xue Li; Elmar Schiebel; Massimo Pancione
Journal:  Trends Mol Med       Date:  2020-02-18       Impact factor: 11.951

Review 3.  Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.

Authors:  Xueqian Zhuang; Hao Zhang; Guohong Hu
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

4.  p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging.

Authors:  Ana M Tormos; Sergio Rius-Pérez; María Jorques; Patricia Rada; Lorena Ramirez; Ángela M Valverde; Ángel R Nebreda; Juan Sastre; Raquel Taléns-Visconti
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

Review 5.  The Consequences of Chromosome Segregation Errors in Mitosis and Meiosis.

Authors:  Tamara Potapova; Gary J Gorbsky
Journal:  Biology (Basel)       Date:  2017-02-08

Review 6.  The impact of mitotic errors on cell proliferation and tumorigenesis.

Authors:  Michelle S Levine; Andrew J Holland
Journal:  Genes Dev       Date:  2018-05-01       Impact factor: 11.361

Review 7.  DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons.

Authors:  Therese Wilhelm; Maha Said; Valeria Naim
Journal:  Genes (Basel)       Date:  2020-06-10       Impact factor: 4.096

Review 8.  Rho signaling research: history, current status and future directions.

Authors:  Shuh Narumiya; Dean Thumkeo
Journal:  FEBS Lett       Date:  2018-05-24       Impact factor: 4.124

9.  p38- and MK2-dependent signalling promotes stress-induced centriolar satellite remodelling via 14-3-3-dependent sequestration of CEP131/AZI1.

Authors:  Maxim A X Tollenaere; Bine H Villumsen; Melanie Blasius; Julie C Nielsen; Sebastian A Wagner; Jiri Bartek; Petra Beli; Niels Mailand; Simon Bekker-Jensen
Journal:  Nat Commun       Date:  2015-11-30       Impact factor: 14.919

10.  Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis.

Authors:  Catrin Youssif; Monica Cubillos-Rojas; Mònica Comalada; Elisabeth Llonch; Cristian Perna; Nabil Djouder; Angel R Nebreda
Journal:  EMBO Mol Med       Date:  2018-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.